Long-acting therapy of schizophrenia.
D000293:Adolescent; D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D001971:Bromocriptine / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000628:therapy; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006220:Haloperidol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010868:Pimozide / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D014291:Trimeprazine / Q000627:therapeutic use
D000978:Antiparkinson Agents; D001569:Benzodiazepines; D010868:Pimozide; D001971:Bromocriptine; D014291:Trimeprazine; C011825:fluphenazine depot; D006220:Haloperidol; C006820:bromperidol; D005476:Fluphenazine